Rachel Mc Minn Neoleukin Therapeutics, Inc. (NLTX) insider trading activity

NLTX Quotes by TradingView

Rachel Mc Minn is Chief Executive Officer of Neoleukin Therapeutics, Inc.. Currently has a direct ownership of 1.27 Million shares of NLTX, which is worth approximately $0. The most recent transaction as insider was on Mar 26, 2025, when has been sold 23,900 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.27M
1.82% 3M change
n/a 12M change
Total Value Held $0

Rachel McMinn Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 26 2025
BUY
Grant, award, or other acquisition
-
23,900 Added 1.84%
1,274,259 Common Stock
Nov 22 2024
BUY
Open market or private purchase
$968,999 $20.4 p/Share
47,500 Added 3.53%
1,297,859 Common Stock
RM

Rachel Mc Minn

Chief Executive Officer
New York, NY

Track Institutional and Insider Activities on NLTX

Follow Neoleukin Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NLTX shares.

Notify only if

Insider Trading

Get notified when an Neoleukin Therapeutics, Inc. insider buys or sells NLTX shares.

Notify only if

News

Receive news related to Neoleukin Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NLTX